Bahr-Hosseini, Mersedeh http://orcid.org/0000-0003-3049-4542
Bikson, Marom
Iacoboni, Marco
Liebeskind, David S.
Hinman, Jason D.
Carmichael, S Thomas
Saver, Jeffrey L.
Funding for this research was provided by:
American Heart Association (18CDA34110160)
Article History
Received: 27 February 2021
Revised: 26 April 2021
Accepted: 26 May 2021
First Online: 1 July 2021
Declarations
:
: Mersedeh Bahr-Hosseini (MBH) receives funding from the American Heart Associaton for developing transcranial direct current stimulation as neuroprotection for treatment of acute cerebral ischemia. MBH has an intellectual property on Transcranial Electrical Stimulation In Stroke Early After Onset.Marom Bikson (MB): The City University of New York holds patents on brain stimulation with MB as inventor. MB has equity in Soterix Medical Inc. MB consults, received grants, assigned inventions, and/or serves on the SAB of Boston Scientific, GlaxoSmithKline, Biovisics, Mecta, Halo Neuroscience, X. MB is supported by grants from the National Institutes of Health: R01NS101362 (MB), R01NS095123 (MB), R01NS112996 (MB), R01MH111896 (MB), R01MH109289 (MB).Jeffrey L Saver (JLS) receives consulting fees for service on clinical trial design committees from Astrocyte Pharma and Hybernia Medical.All the other authors declare no competing interests.